Dynamic cell reprogramming without gene editing making personalized medicine scalable. We're starting with cancer and soon extending longevity.
CellRep is revolutionizing cell therapy based on our co-founder Dr. Federico Perdomo's groundbreaking discovery that cells are programmable biological supercomputers. While at Institut Pasteur, Dr. Perdomo demonstrated that dysfunctional T cells could be reprogrammed with small molecules to emulate the extraordinary properties of T cells from HIV natural controllers—creating rejuvenated fighters with enhanced survival, polyfunctionality, and metabolic plasticity.
Our AI-powered platform expands on this breakthrough through our integrated In Silico, In Vitro, and In Vivo approach, dynamically reprogramming T cells without genetic modification to address the critical limitations in today's CAR-T therapies: poor efficacy in solid tumors, lengthy manufacturing times, and prohibitive costs.
We've already identified 15+ novel molecular targets and achieved a 2.5x improvement in T cell functionality—47% better than Dr. Perdomo's original breakthrough. Our technology produces more polyfunctional, "younger" T cells with potential to reduce manufacturing time by 45% while improving therapeutic outcomes by 50%.
With strategic partnerships established with major research institutions and engagement from leading pharmaceutical companies, we're transforming the $7B CAR-T market (projected to reach $188B by 2034) while building the definitive bio-compiler for cellular medicine across multiple therapeutic areas.
Company Details
- Employees
- 6
- Founded
- -
- Address
- The Critical Limitations In Today's Car-T Therapies: Poor Efficacy In Solid Tumors
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://cellrep.bio
Cellrep Questions
Cellrep's website is https://cellrep.bio
Cellrep's LinkedIn profile is https://www.linkedin.com/company/cellrep
Cellrep has
6 employees.
View email and phone details for 6
employees at Cellrep.
Cellrep's industry is
Biotechnology Research
Cellrep's top competitors are
Bioblends,
Polymera,
Biodiversity Intelligence,
Gridx,
Apasomics,
Migma,
Cyanomin,
Invitrall,
Microin,
Bioplastix.
Cellrep's categories are Biotechnology Research
Cellrep's founding year is 2024
